These miR-107-rich tumor-derived exosomes absorbed by HLA-DR CD33+ MDSC could target and inhibit the expression of DICER1 and PTEN genes, and subsequently promote the amplification of MDSC (92). This evidence concerns the gene PTEN and neoplasm.